{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:36:42Z","timestamp":1786999002545,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1016\/s0165-6147(00)01639-4","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T15:57:20Z","timestamp":1027612640000},"page":"140-146","source":"Crossref","is-referenced-by-count":79,"title":["Arylamine N-acetyltransferases \u2013 of mice, men and microorganisms"],"prefix":"10.1016","volume":"22","author":[{"given":"Anna","family":"Upton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0165-6147(00)01639-4_BIB1","first-page":"25","article-title":"Arylamine N-acetyltransferases","volume":"37","author":"Weber","year":"1985","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.2.5197.485","article-title":"Genetic control of isoniazid acetylation in man","volume":"2","author":"Evans","year":"1960","journal-title":"Br. Med. J."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB3","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0140-6736(82)90810-8","article-title":"Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer","volume":"2","author":"Cartwright","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00008571-200006000-00002","article-title":"Update on consensus arylamine N-acetyltransferase gene nomenclature","volume":"10","author":"Hein","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB6","first-page":"727","article-title":"International collaborative study on genetic susceptibility to environmental carcinogens","volume":"8","author":"Taioli","year":"1999","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB7","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1172\/JCI105306","article-title":"Partial purification and properties of the isoniazid transacetylase in human liver: its relationship to the acetylation of p-aminosalicylic acid","volume":"44","author":"Jenne","year":"1965","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JB.181.4.1343-1347.1999","article-title":"Cloning and characterisation of arylamine N-acetyltransferase genes of M. smegmatis and M. tuberculosis; increased expression results in isoniazid resistance","volume":"181","author":"Payton","year":"1999","journal-title":"J. Bacteriol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB9","unstructured":"Payton, M.A. et al. Characterisation of Eubacterial arylamine N-acetyltransferases \u2013 identification and comparison of eighteen members of the protein family with conserved active site cysteine, histidine and aspartate residues. Microbiology (in press)"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-4274(97)03870-8","article-title":"Evidence for arylamine N-acetyltransferase activity in the bacterium Helicobacter pylori","volume":"91","author":"Chung","year":"1997","journal-title":"Toxicol. Lett."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB12","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/S0021-9258(18)62221-5","article-title":"Acetyl-coenzyme A: arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate","volume":"246","author":"Riddle","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB13","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1016\/S0021-9258(18)68531-X","article-title":"Arylamine N-acetyltransferase from chicken liver","volume":"263","author":"Ohsako","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB14","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1073\/pnas.86.23.9554","article-title":"N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits","volume":"86","author":"Blum","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008571-199804000-00009","article-title":"Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like gene","volume":"8","author":"Trepanier","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB16","doi-asserted-by":"crossref","unstructured":"Upton, A.M. and Sim, E. (1999) Bovine Arylamine N-acetyltransferase. Biochem. Soc. Trans. 28, Part 2 (Supplement)","DOI":"10.1042\/bst028a043"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB17","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/hmg\/9.16.2435","article-title":"An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes","volume":"9","author":"Sim","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/mol.57.3.468","article-title":"Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells","volume":"57","author":"Butcher","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-2952(97)00140-8","article-title":"Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes","volume":"54","author":"Trepanier","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB20","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1016\/S0021-9258(18)42462-3","article-title":"Involvement of Cys 69 in the catalytic mechanism of NhoA of Salmonella typhimurium","volume":"267","author":"Watanabe","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1367-5931(99)00014-9","article-title":"Lessons from the rifamycin biosynthetic gene cluster","volume":"3","author":"Floss","year":"1999","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB22","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1016\/S0021-9258(18)68529-1","article-title":"On the active site of liver acetyl-CoA arylamine N-acetyltransferase from rapid acetylator rabbits (III\/J)","volume":"263","author":"Andres","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB23","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1016\/S0021-9258(18)42528-8","article-title":"Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in E. coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2","volume":"267","author":"Dupret","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/bj3230207","article-title":"Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis","volume":"323","author":"Delomenie","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/76783","article-title":"Structure of arylamine N-acetyltransferase reveals a catalytic triad","volume":"7","author":"Sinclair","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0165-6147(00)01531-5","article-title":"The first 3D structure of arylamine N-acetyltransferase reveals a protease-like catalytic triad","volume":"21","author":"Payton","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-2952(96)00592-8","article-title":"A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis","volume":"53","author":"Sinclair","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/0264-6021:3480159","article-title":"Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2","volume":"348","author":"Goodfellow","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/prep.1997.0734","article-title":"Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion protein","volume":"10","author":"Sticha","year":"1997","journal-title":"Protein Expres. Purif."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0378-4274(99)00226-X","article-title":"N-acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis","volume":"112\u2013113","author":"Hein","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008571-199802000-00008","article-title":"Identification and characterisation of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe","volume":"8","author":"Hughes","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0027-5107(97)00038-9","article-title":"The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studie","volume":"376","author":"Windmill","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/gut.42.3.402","article-title":"Expression of arylamine N-acetyltransferase in human intestine","volume":"42","author":"Hickman","year":"1998","journal-title":"Gut"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000134601","article-title":"Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours","volume":"77","author":"Matas","year":"1997","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/dna.1990.9.193","article-title":"Human arylamine N-acetyltransferase genes: isolation, chromosomal localisation and functional expression","volume":"9","author":"Blum","year":"1990","journal-title":"DNA Cell Biol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB36","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/0006-291X(91)90676-X","article-title":"Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases","volume":"177","author":"Ebisawa","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB37","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1016\/S0021-9258(19)39609-7","article-title":"Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases of human liver","volume":"265","author":"Ohsako","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB38","first-page":"5226","article-title":"Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue","volume":"55","author":"Bell","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008571-199802000-00009","article-title":"Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations","volume":"8","author":"Butcher","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0006-2952(97)00478-4","article-title":"Genotyping human arylamine N-acetyltransferase type 1 (NAT1). The identification of two novel allelic variants","volume":"55","author":"Payton","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB41","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/S0006-2952(99)00269-5","article-title":"Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1)","volume":"58","author":"Bruhn","year":"1999","journal-title":"Biochem.Pharmacol"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0773.1998.tb01461.x","article-title":"Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2","volume":"83","author":"Smelt","year":"1999","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/mol.58.2.288","article-title":"Characterisation of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1","volume":"58","author":"De Leon","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00008571-199902000-00014","article-title":"Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk","volume":"9","author":"Henning","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB45","first-page":"1354","article-title":"Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2*9)","volume":"23","author":"De Leon","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB46","first-page":"261","article-title":"Developmental expression of N-acetyltransferases in C57Bl\/6 mice","volume":"27","author":"Mitchell","year":"1999","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1096-9926(199811)58:5<174::AID-TERA3>3.0.CO;2-Q","article-title":"Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain","volume":"58","author":"Stanley","year":"1998","journal-title":"Teratology"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB48","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/oxfordjournals.jhered.a110546","article-title":"Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltranserase","volume":"79","author":"Mattano","year":"1988","journal-title":"J. Hered."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000015648","article-title":"Chromosomal localisation and mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel non-coding exon for Nat2","volume":"90","author":"Fakis","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB50","first-page":"13","article-title":"Characterisation of a hormone response element in the mouse N-acetyltransferase 2 (Nat2*) promoter","volume":"7","author":"Estrada-Rogers","year":"1998","journal-title":"Gene Expression"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB51","first-page":"139","article-title":"Tissue and gender specific expression of N- acetyltransferase 2 (NAT2*) during development of the outbred mouse strain CD-1","volume":"28","author":"Estrada-Rogers","year":"2000","journal-title":"Drug Metab. Dipos."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<376::AID-GCC10>3.0.CO;2-H","article-title":"Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NATI cosmid clone: an investigation in bladder cancer by interphase, Genes","volume":"25","author":"Stacey","year":"2000","journal-title":"Chromosomes Cancer"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB53","first-page":"3537","article-title":"Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer","volume":"55","author":"Bell","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB54","first-page":"557","article-title":"Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene\u2013gene interaction in the susceptibility to childhood acute lymphoblastic leukemia","volume":"9","author":"Krajinovic","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev. Bio. Prev."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00008571-199808000-00002","article-title":"N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk","volume":"8","author":"Bouchardy","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB56","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/bjc.1998.151","article-title":"N-acetyl transferase 1: two polymorphisms in coding sequence identified in colorectal cancer patients","volume":"77","author":"Hubbard","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB57","first-page":"225","article-title":"Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking","volume":"6","author":"Okkels","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00008571-200006000-00003","article-title":"Molecular analysis of the N-acetyltransferase 1 gene (NAT1*) using polymerase chain reaction-restriction fragment-single strand conformation polymorphism assay","volume":"10","author":"Lo Guidance","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/gut.41.2.229","article-title":"N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions","volume":"41","author":"Hubbard","year":"1997","journal-title":"Gut"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB60","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jmg.34.9.758","article-title":"A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid","volume":"34","author":"Smith","year":"1997","journal-title":"J. Med. Genet."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB61","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0006-2952(91)90282-A","article-title":"N-acetyltransferase polymorphism. Comparison of genotype and phenotype in humans","volume":"42","author":"Hickman","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB62","first-page":"581","article-title":"Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity","volume":"57","author":"Cascorbi","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00008571-199902000-00016","article-title":"Pitfalls in N-acetyltransferase 2 genotyping","volume":"9","author":"Cascorbi","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB64","first-page":"3603","article-title":"The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene\u2013gene-exposure three-way interaction","volume":"58","author":"Taylor","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB65","first-page":"233","article-title":"N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk","volume":"8","author":"Zheng","year":"1999","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/S0165-6147(00)01639-4_BIB66","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/carcin\/17.10.2125","article-title":"Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas","volume":"17","author":"Probst-Hench","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00008571-199806000-00009","article-title":"Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas","volume":"8","author":"Lin","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB68","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/carcin\/14.8.1689","article-title":"Genotype\/phenotype discordance for human arylamine N-acetyltrasferase (NAT2) reveals a new slow-acetylator allele common in African-Americans","volume":"14","author":"Bell","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB69","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/carcin\/19.10.1803","article-title":"A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people","volume":"19","author":"Katoh","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB70","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bjc.6690727","article-title":"Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer","volume":"81","author":"Hsieh","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00008571-200002000-00010","article-title":"Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population","volume":"10","author":"Dhaini","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB72","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1073\/pnas.88.12.5237","article-title":"Molecular mechanism of slow acetylation of drugs and carcinogens in humans","volume":"88","author":"Blum","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB73","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1073\/pnas.88.14.6333","article-title":"Diverse point mutations in the human gene for polymorphic N-acetyltransferase","volume":"88","author":"Vatsis","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00008571-199210000-00004","article-title":"Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants","volume":"2","author":"Hickman","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0165-6147(00)01639-4_BIB75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00008571-199406000-00003","article-title":"Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene","volume":"4","author":"Lin","year":"1994","journal-title":"Pharmacogenetics"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614700016394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614700016394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T21:29:01Z","timestamp":1620682141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614700016394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0165614700016394"],"URL":"https:\/\/doi.org\/10.1016\/s0165-6147(00)01639-4","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}